Results 271 to 280 of about 17,843,832 (369)

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Recommender systems for obesity prevention: Scoping review of reviews. [PDF]

SAGE Open Med
De Santis KK, Stiens L, Christianson L, Forberger S.   +3 more
europepmc   +1 more source

Book Review: Numerische Behandlung von Differentialgleichungen [PDF]

, 1953
W. E. Milne
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Book Reviews [PDF]

, 2014
Reviews, Book
core   +1 more source

Therapeutic strategies for low anterior resection syndrome: an umbrella review of systematic reviews. [PDF]

Int J Colorectal Dis
Liu T, Jiao X, Hu C, Su R, Dong J, Niu Q.   +5 more
europepmc   +1 more source

Book Review: IV. Church History: Mission und Ausbreitung des Christentums in den ersten drei Jahrhunderten [PDF]

, 1907
W. J. McGlothlin
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

How are patient partners involved in health service research? A scoping review of reviews. [PDF]

Res Involv Engagem
Tscherning SC, Jensen AL, Bekker HL, Vedelø TW, Finderup J, Rasmussen GS, Østergaard JA, Jensen FO, Rodkjaer LØ.   +8 more
europepmc   +1 more source

Review of Ueber die Abstraktion der Gleichheit. [PDF]

, 1909
Thomas Verner Moore
openalex   +1 more source